logo-loader

Cellmid Limited

Receive alerts
Market:
ASX
Market Cap:
$21.73 m
Price
0.23 AUD
Change
-8.16%
52 weeks high
0.31
52 weeks low
0.17

In brief

Cellmid Ltd (ASX:CDY) is an Australian life sciences company with lead programs in multiple disease indications.

Deep dive We explore the investor case for growth companies

Snapshot

Through wholly-owned subsidiaries such as Lyramid, Kinera and Advangen, the company develops and markets innovative novel therapies as well as diagnostic tests for inflammatory and fibrotic diseases, cancer, ischemic diseases of the heart and hair loss.